Liu Sha, Huang Fang, Ru Guoqing, Wang Yigang, Zhang Bixiang, Chen Xiaoping, Chu Liang
Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Cancer Center, Department of Pathology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
Front Oncol. 2022 Jun 30;12:902820. doi: 10.3389/fonc.2022.902820. eCollection 2022.
Hepatocellular carcinoma (HCC) is the subtype of liver cancer with the highest incidence, which is a heterogeneous malignancy with increasing incidence rate and high mortality. For ethical reasons, it is essential to validate medical clinical trials for HCC in animal models before further consideration on humans. Therefore, appropriate models for the study of the pathogenesis of the disease and related treatment methods are necessary. For tumor research, mouse models are the most commonly used and effective model, which is closer to the real-life environment, and the repeated experiments performed on it are closer to the real situation. Several mouse models of HCC have been developed with different mouse strains, cell lines, tumor sites, and tumor formation methods. In this review, we mainly introduce some mouse HCC models, including induced model, gene-edited model, HCC transplantation model, and other mouse HCC models, and discuss how to choose the appropriate model according to the purpose of the experiments.
肝细胞癌(HCC)是肝癌中发病率最高的亚型,是一种异质性恶性肿瘤,发病率不断上升且死亡率高。出于伦理原因,在进一步考虑应用于人类之前,有必要在动物模型中验证针对HCC的医学临床试验。因此,需要合适的模型来研究该疾病的发病机制和相关治疗方法。对于肿瘤研究而言,小鼠模型是最常用且有效的模型,它更接近现实生活环境,在其上进行的重复实验也更接近真实情况。已经利用不同的小鼠品系、细胞系、肿瘤部位和肿瘤形成方法开发了多种HCC小鼠模型。在本综述中,我们主要介绍一些小鼠HCC模型,包括诱导模型、基因编辑模型、HCC移植模型以及其他小鼠HCC模型,并讨论如何根据实验目的选择合适的模型。